The Western blotting experiment showed the expression of p53 was downregulated significantly (p < 0.05) at a higher dose (10 mg/kg) of peptide YWCS in the hippocampus and frontal cortex as compared to the AD group. Here, TP53 is linked to Alzheimer disease.